Showing results 1 to 1 of 1
Issue Date | Title | Journal Title |
---|---|---|
2022 | Open-label, multi-center, phase II study of adjuvant pemetrexed plus cisplatin for completely resected stage IB to IIIA adenocarcinoma of the lung: APICAL trial | TRANSLATIONAL LUNG CANCER RESEARCH |